CorFlow Therapeutics
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$48.6M
CorFlow Therapeutics AG develops and validates the CoFl system for diagnosing and treating Microvascular Obstruction (MVO) in heart attack patients.
Focus Areas
Microvascular Obstruction
heart attack
diagnosis
treatment
pivotal trials
therapeutic delivery
Investors
